Impact of the initial site of recurrence on prognosis after curative surgery for primary lung cancer

Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer

(2020) Chengdi Wang et al.   BMC CANCER

Clinical significance of expression level of CX3CL1–CX3CR1 axis in bone metastasis of lung cancer

(2020) Y. Liu et al.   Clinical & Translational Oncology

Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients

(2019) Sriram Sridhar et al.   Clinical Lung Cancer

Definitive Local Therapy for Oligo-recurrence in Patients With Completely Resected Non–small Cell Lung Cancer

(2019) Haruhisa Matsuguma et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery

(2018) Tetsuya Isaka et al.   BMC CANCER

A meta-analysis survey of appropriate bone turnover markers in the detection of bone metastasis in lung cancer

(2017) Jianda Huang et al.   International Journal of Clinical Oncology

Impact of the oncogenic status on the mode of recurrence in resected non-small cell lung cancer

(2016) Tetsuya Mizuno et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival

(2015) Hideki Ujiie et al.   JOURNAL OF CLINICAL ONCOLOGY

Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib

(2015) Kuan-Li Wu et al.   LUNG CANCER

Metastatic sites and survival in lung cancer

(2014) M. Riihimäki et al.   LUNG CANCER

Prognostic Factors and the Significance of Treatment After Recurrence in Completely Resected Stage I Non-small Cell Lung Cancer

(2013) Yoshihisa Shimada et al.   CHEST

Local recurrence following lung cancer surgery: Incidence, risk factors, and outcomes

(2013) David Fedor et al.   SURGICAL ONCOLOGY-OXFORD

Results of Long-Term Follow-Up of Patients With Completely Resected Non-Small Cell Lung Cancer

(2012) Chiaki Endo et al.   ANNALS OF THORACIC SURGERY

Specific organ metastases and survival in small cell lung cancer

(2012) KENSUKE NAKAZAWA et al.   Oncology Letters

Outcomes of Patients With Isolated Adrenal Metastasis From Non-Small Cell Lung Carcinoma

(2011) Dan J. Raz et al.   ANNALS OF THORACIC SURGERY

Lung Cancer: Epidemiology, Etiology, and Prevention

(2011) Charles S. Dela Cruz et al.   CLINICS IN CHEST MEDICINE

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Resection of Pulmonary Metastasis of Non-small Cell Lung Cancer

(2009) Kenichi Okubo et al.   Journal of Thoracic Oncology

Postrecurrence survival in patients with stage I non-small cell lung cancer

(2008) Tatsuo Nakagawa et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY